For people at risk of heart disease, weight reduction and improved glucose control can change risk profiles over time
Plasma half-life is a poor proxy for duration of effect in this class
In response to clinical needs for large amounts of viable NK cells, alternative sources such as induced pluripotent stem cells, umbilical cord blood and cell lines (such as NK-92) have been evaluated both pre-clinically and clinically
This approach was chosen to mirror the HbA1c progression used by NICE for evaluating SGLT2 inhibitors as monotherapy in the UK and to reflect common clinical practice in which, due to the progressive nature of type 2 diabetes, glycaemic control cannot be maintained indefinitely by the addition of one medication [7, 31]
Then, they move to 1200mg for those wanting a stronger effect or continuing an existing treatment plan
Options include: Returning to the previous dose: If heartburn appeared at 10mg but was absent at 7.5mg, stepping back to 7.5mg for a longer period before attempting escalation again often works